shares of pacific edge ltd jumped by nearly onefifth on wednesday after a large us hospital operator agreed to make it easier for clinicians to order and view results for the companys bladdercancer test pacific edge shares were up more than 18 at 84 new zealand cents 545 us cents in nzx trading they remain down 37 so far this year due to reduced appetite for growth stocks hospital operator kaiser permanente has agreed to add pacific edges tests to an electronic medical records system in a project that will take several months to complete and could drive greater use of the proprietary test pacific edge said it was an important commercial milestone the company has been operating at a loss but analysts have been expecting significant growth after its bladdercancer test qualified for us medical insurance coverage